Skip to main content
Equibles

UBS Group AG

Position in IMDX — Insight Molecular Diagnostics Inc.

CIK 1610520 ZURICH, V8
Back to IMDX Full portfolio

Position in IMDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$314,327
+$239,705 QoQ
Shares Held
53,276
+134.2% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 40 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in IMDX Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. IMDX ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 2,521,208 $1,264,032,836
2 DHR
Danaher Corp /De/
 3,243,524 $617,826,447
3 WAT
Waters Corp /De/
 694,851 $260,596,916
4 A
Agilent Technologies, Inc.
 1,574,629 $209,157,967
5 RVTY
Revvity, Inc.
 1,864,464 $207,440,262
6 IDXX
Idexx Laboratories Inc /De
 364,663 $191,973,186
7 DGX
Quest Diagnostics Inc
 888,906 $188,403,625
8 MTD
Mettler Toledo International Inc/
 128,025 $163,553,216

All Filings in IMDX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $314,327 53,276
2026-03-31 $74,622 22,751
2025-12-31 $22,057 2,941
2025-09-30 $9,009 2,714
2025-06-30 $46,401 15,365
2025-03-31 $8,121 2,654
2024-12-31 $6,458 2,714
2024-09-30 $2,379 835
2024-06-30 $2,462 835
2024-03-31 $2,530 864
2023-12-31 $3,447 1,379
2023-09-30 $3,196 1,025